Skip to main content

mHeath based Diabetes Management in India - Remote monitoring Tools

In the past we have read a lot of research projects that determine the outcomes based overview of Diabetes management and the use of remote monitoring tools. We have spoken to Doctors,  technologists as well as equipment manufacturers and all of these available tools represent a breakthrough for clinician/patient communication to enhance disease management and improve health outcomes.

However, for India we were yet to find out the drivers, challenges, consumer behaviour, expected adoption level and value add to the end users. Here is a recent study undertaken by HealthCursor Consulting Group India to understand the DM market better.

SURVEY questionnaire:

1. If you are given a Glucometer (blood sugar check machine) for free, will you check your blood sugar daily ?
1)      Yes
2)      No

2. Your mobile phone will automatically send this data to your Doctor. Your Doctor will then SMS, EMAIL or call you if your sugar is not in control. How much you will you easily pay for this service? (Note: the doctor will not disturb you in case of normal readings.)
1)      Rs 1000-2000/month
2)      Rs 500-900/month
3)      Rs 100-400/month

3. Will you feel more comfortable if you do not have to do your blood sugar monitoring yourself but a nurse sitting in a nearby chemist store/pharmacy does it for you? In this case you will have to step out of your house but will this give you more confidence?
1)      Yes, I will feel better if a nurse does that and I don't mind driving to the chemist store.
2)      No, I would like to do it at home myself

4. Are you using a Glucometer already? Would you mind buying a new Glucometer if that connects with your phone and transfers your data automatically to the doctor?
1)      Yes, I have a Glucometer and Yes, I will buy a new one if it is the same price as my old one but has advance features like what is mentioned above.
2)      Yes, I have a Glucometer and No, I don't want a new Glucometer.
3)      No, I don't have a Glucometer but Yes, I will buy a new one if it is the same price as the one available in the market but has advance features like what is mentioned above
4)      No, I don't have a Glucometer but I will only buy known conventional brands Glucometer and will not trust any advance ones.

5. What all a Diabetic should invest in?
1)      Glucometer
2)      Glucometer, Doctor Consultation
3)      Glucometer, Doctor Consultation, Daily Glucose monitoring and advice
4)      Glucometer, Doctor Consultation,Daily Glucose monitoring and advice, Diagnostic checkups
5)      Glucometer, Doctor Consultation, Daily Glucose monitoring and advice, Diagnostic checkups, Diet plan, Exercise plan, Lifestyle and wellness plan

SAMPLE: Volunteers from the following companies participated in this survey.

Popular posts from this blog

Healthcare On Mobiles: Featured post- mHealth fighting malnutrition

Healthcare On Mobiles: Featured post- mHealth fighting malnutrition
Malnutrition is a byword in the forested hills of the Melghat region inhabited mostly by Korku Adivasis. Every year 400-500 children between the ages of 0 and 6 die in the region, comprising Chikhaldhara and Dharni taluks, according to official figures from 2005.

The Problem: Thousands of kids die every year in the tribal area of Melghat (Maharashtra, India) due to lack of medical attention and nutritional support. Increased incidence and rapid spread of infectious diseases such as pneumonia, typhoid, and dysentery are primary cause of high child mortality. Situation worsens during monsoon when the food supplies are low and the communicable diseases are at their peak.

Melghat is also a place known for high infant mortality rate. Some reasons for the health crisis in Melghat include lack of infrastructure, under-equipped and under-staffed public health and ICDS centres, the tradition of early marriages and early mothe…

The Formula of Driver and Demand- Indian Startups story

The healthcare industry is currently experiencing change at an unprecedented rate. Change is not only occurring in the technology used in diagnostics and care delivery, but this change is so fundamental that it could, and likely will, fundamentally alter the business model of the industry.
Today we have fitness bands, healthcare apps, appointment schedulers, health chats and several such means to access healthcare but one thing that all of this does not necessarily correlate with high quality of care or better outcomes. We need to understand that “Not even a Ferrari will get us to our destination without a driver.”Formula of Driver:
Driver = (Need + Incentive) where;
Incentive = (Value + Reward) Need = (Gap + Demand)
To define the best drivers, we need to first address the need. Need might not make economic or business sense but it is the best opportunity to leave an impact. No one remembers how much business a “Mughal-e-Azam” or “Usual suspects” did but everyone remembers that these were…

Why we never noticed ZIKA?- Indian Research and Development

“Zika had 'disappeared' because it wasn’t worth worrying about and people weren’t paying attention.”

Zika virus was first identified in 1947 in a sentinel monkey that was being used to monitor for the presence of yellow fever virus in the Zika Forest of Uganda. At this time cell lines were not available for studying viruses, so serum from the febrile monkey was inoculated intra-cerebrally into mice. All the mice became sick, and the virus isolated from their brains was called Zika virus. The same virus was subsequently isolated from Aedes africanus mosquitoes in the Zika forest.

In 1950, when some serological studies were being done, it was found that we humans developed antibodies against this virus. Further studies revealed evidence of infection in other African countries, including Uganda, Tanzania, Egypt, Central African Republic, Sierra Leone, and Gabon, as well as Asia (India, Malaysia, Philippines, Thailand, Vietnam, Indonesia). The virus circulating in Brazil is an Asi…